Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care

Rajan Yadav, Masaoki Ito, Hideki Ujiie, Shuta Ohara, Yasuhiro Tsutani, Goutham Sunny

Open source

DOI
10.3390/cancers18183043
Published
2026-09-19
Container
Cancers
Publisher
MDPI AG
Open access
unknown

Credibility signals

uncertain Score 64/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.3390/cancers18183043,
  title = {Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care},
  author = {Rajan Yadav and Masaoki Ito and Hideki Ujiie and Shuta Ohara and Yasuhiro Tsutani and Goutham Sunny},
  year = {2026},
  journal = {Cancers},
  doi = {10.3390/cancers18183043},
  url = {https://doi.org/10.3390/cancers18183043}
}

RIS

TY  - JOUR
TI  - Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care
AU  - Rajan Yadav
AU  - Masaoki Ito
AU  - Hideki Ujiie
AU  - Shuta Ohara
AU  - Yasuhiro Tsutani
AU  - Goutham Sunny
PY  - 2026
JO  - Cancers
DO  - 10.3390/cancers18183043
UR  - https://doi.org/10.3390/cancers18183043
ER  - 

APA

Yadav, R., Ito, M., Ujiie, H., Ohara, S., Tsutani, Y., & Sunny, G. (2026). Circulating Tumor DNA-Based Molecular Residual Disease in Early-Stage Non-Small-Cell Lung Cancer: Biology, Assays, and the Path Toward MRD-Guided Care. Cancers. https://doi.org/10.3390/cancers18183043

Source records